Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Pansclerotic Morphea Following Covid-19: A Case Report and Review of Literature on Rheumatologic and Non-Rheumatologic Dermatologic Immune-Mediated Disorders Induced by Sars-Cov-2 Publisher



Lotfi Z1, 2 ; Haghighi A3 ; Akbarzadehpasha A4 ; Mozafarpoor S5 ; Goodarzi A2
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Dermatology, Faghihi Hospital, Shiraz University of Medical Sciences, Shiraz, Iran
  2. 2. Department of Dermatology, Rasool Akram Medical Complex, Iran University of Medical Sciences, Tehran, Iran
  3. 3. Department of Rheumatology, Rasool Akram Medical Complex, Iran University of Medical Sciences, Tehran, Iran
  4. 4. Department of Internal Medicine, Rasool Akram Medical Complex, Iran University of Medical Sciences, Tehran, Iran
  5. 5. Department of Dermatology, Skin Diseases and Leishmaniasis Research Center, Isfahan University of Medical Sciences, Isfahan, Iran

Source: Frontiers in Medicine Published:2021


Abstract

While mucocutaneous manifestations of COVID-19 have been frequently reported and added to our knowledge every day during the pandemic, another issue is the COVID-related diseases that can present as intensified lesions of underlying diseases, a new disease, or changes in the behavior of an old lesion. Given that immune system overreaction and cytokine storm are among the most prominent events in COVID-19, the incidence of autoimmune diseases is expected to increase after COVID-19, as confirmed in several reports. To increase the body of knowledge about short- and long-term outcomes of COVID-19 for specialists, it is essential that similar cases be reported and collected for years to come. The present study investigated a case of pansclerotic morphea that rapidly progressed a few weeks after infection with COVID-19 in a 57-year-old woman with no history of any autoimmune skin or rheumatic diseases. She was prescribed outpatient COVID-19 treatment of azithromycin, vitamins D and C, and then quarantined for 2 weeks. The manifestations of the disease were exacerbated at each follow-up and sampling visit at short intervals. This kind of pansclerotic morphea is reported for the first time. Copyright © 2021 Lotfi, Haghighi, Akbarzadehpasha, Mozafarpoor and Goodarzi.
Other Related Docs
13. Autoimmune Encephalitis Due to Covid-19 in a Young Patient, Iranian Journal of Child Neurology (2023)
14. A Narrative Review of Covid-19: The New Pandemic Disease, Iranian Journal of Medical Sciences (2020)
23. Sars-Cov-2 (Covid-19): New Discoveries and Current Challenges, Applied Sciences (Switzerland) (2020)
25. Covid-19 Management in the Emergency Ward, Journal of Research in Medical Sciences (2021)
26. A Comprehensive Review of Therapeutic Options for Covid-19, Ethiopian Journal of Health Development (2022)
29. Clinical Display, Diagnostics and Genetic Implication of Novel Coronavirus (Covid-19) Epidemic, European Review for Medical and Pharmacological Sciences (2020)
30. Movement Disorders Associated With Covid-19, Parkinson's Disease (2021)
40. Abdominal Signs and Symptoms of Covid-19 in Children, Archives of Pediatric Infectious Diseases (2021)
42. Covid-19 and Acute Pancreatitis: A Case Report, Acta Medica Iranica (2021)